BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25842754)

  • 1. Progression of conjunctival primary acquired melanosis (PAM) to widely spreaded malignant melanoma.
    Jandroković S; Popović-Suić S; Mandić JJ; Kuzman T; Skegro I; Kutija MB; Masnec S; Kalauz M
    Coll Antropol; 2014 Dec; 38(4):1187-90. PubMed ID: 25842754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento.
    Paridaens AD; McCartney AC; Hungerford JL
    Br J Ophthalmol; 1992 Mar; 76(3):163-5. PubMed ID: 1540561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
    Stacy RC; Kenyon KR; Jakobiec FA; Colby KA
    Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conjunctival melanoma at corneoscleral limbus on primary acquired melanosis. A case report].
    Chazalon-Pauleau E; Roux L; Patte JH; Pommier S; Bonnet D; Meyer F
    J Fr Ophtalmol; 2007 Oct; 30(8):e22. PubMed ID: 17978670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary acquired melanosis with atypia treated with mitomycin C.
    Anandajeya WV; Corrêa ZM; Augsburger JJ
    Int Ophthalmol; 2009 Aug; 29(4):285-8. PubMed ID: 18438612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases.
    Jakobiec FA; Rini FJ; Fraunfelder FT; Brownstein S
    Ophthalmology; 1988 Aug; 95(8):1058-70. PubMed ID: 3231444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma arising from unusual conjunctival blue nevus.
    Demirci H; Shields CL; Shields JA; Eagle RC
    Arch Ophthalmol; 2000 Nov; 118(11):1581-4. PubMed ID: 11074819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant melanoma on primary acquired conjunctival melanosis].
    Meyer A; D'Hermies F; Schwartz L; Morel X; Elmaleh C; Renard G
    J Fr Ophtalmol; 1999 Nov; 22(9):983-6. PubMed ID: 10609177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pigmented conjunctival lesions.
    Oellers P; Karp CL
    Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
    Sugiura M; Colby KA; Mihm MC; Zembowicz A
    Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focus on clinical and pathological management of conjunctival melanocytic tumors].
    Lassalle S; Caujolle JP; Leger F; Maschi C; Gastaud L; Nahon-Esteve S; Thariat J; Baillif S; Hofman P
    Ann Pathol; 2018 Jun; 38(3):153-163. PubMed ID: 29803361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma of the conjunctiva.
    Folberg R; McLean IW; Zimmerman LE
    Hum Pathol; 1985 Feb; 16(2):136-43. PubMed ID: 3972396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
    Cid-Bertomeu P; Huerva V
    Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
    Harooni H; Schoenfield LR; Singh AD
    Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic acquired melanosis.
    Gonder JR; Wagoner MD; Albert DM
    Ophthalmology; 1980 Aug; 87(8):835-40. PubMed ID: 7443216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.